VC firm
Brace Pharmaceuticals
- Investor type
- VC
- Investing status
- Activeas of 2026-09-22Source (opens in a new tab)
- Headquarters
- Atlanta, GA, United States
- Legal name
- Brace Pharma Capital, LLC
Claim, correct or request removal
Record updated 22 September 2026
About
Brace Pharma Capital is a strategic investment firm formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors.
Investment approach
- Thesis
- At Brace Pharma Capital, we invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment optionsSource (opens in a new tab)
- Takes board seats
- Yes
- Eligibility
- Therapy Innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options Development Phase Clinical stage projects with potential to go to market in 3-5 years Pre-clinical stage projects with predictive animal models and potential to go to market in 5-7 years Development Strategy High probability of technical and regulatory success with well defined, FDA validated, clinical efficacy endpoints Orphan Drug Development Preference for disease modifying treatments for debilitating orphan diseases U.S. Market Potential In excess of $200M revenue potential Specialty Sales Force Up to 100 representatives Management Highly experienced management team with an established track record of successful pharmaceutical development Intellectual Property Minimum of 7 year of patent life/market exclusivity
- Traction requirement
- Clinical stage projects with potential to go to market in 3-5 years Pre-clinical stage projects with predictive animal models and potential to go to market in 5-7 years
- Investing status notes
- If you would like to be considered as a candidate investment company please contact us.
Locations
- Headquarters
- Atlanta, GA, United States
Loading relationship preview